The QualityStocks Daily Monday, October 18th, 2021

Today's Top 3 Investment Newsletters

QualityStocks(PNXLF) $0.6610 +67.09%

InvestorPlace(IO) $2.1800 +56.83%

SeriousTraders(KAVL) $1.6100 +18.38%

The QualityStocks Daily Stock List

Aziyo Biologics (AZYO)

StreetInsider reported earlier on Aziyo Biologics (AZYO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Aziyo Biologics Inc. (NASDAQ: AZYO) is a regenerative medicine firm that is engaged in developing regenerative medical products which address various markets, including the soft tissue reconstruction, orthopedic and cardiovascular markets.

The firm has its headquarters in Silver Spring, Maryland and was incorporated in 2015, on August 6th. It operates as part of the pharmaceutical and medicine manufacturing industry. The firm serves consumers in the United States.

The company’s objective is to improve outcomes in patients undergoing surgery, with a focus on patients who are receiving implantable medical devices. Its products have been designed to address unmet clinical needs with the aim being to avoid complications linked to medical device implants and promote healthy tissue formation. These complications include implant rejection, capsular contraction and scar-tissue formation.

The enterprise’s products include a pre-hydrated HADM known as SimpliDerm, which has been designed to replace or repair inadequate or damaged integumental tissues; and CanGaroo, which has been designed to decrease the risk of infection after an electronic device has been surgically implanted in a patient’s body. It also develops a patch material known as VasCure, which reconstructs and repairs the peripheral vasculature; Tyke, which can be used in infants and neonates to repair pericardial structures; and OsterGro V, ViBone an FiberCel, which have been developed to preserve and protect native bone cells. The enterprise sells its products to hospitals and other healthcare facilities via independent sales agents, commercial partners and its direct sales force.

The company recently released its latest financial results for 2021, which show improvements in net sales. It is now focused on advancing its CanGaroo product and submitting it to the FDA for approval by 2022. The product’s success will bring additional revenue as well as investors into the company.

Aziyo Biologics (AZYO), closed Monday's trading session at $5.5068, up 1.0422%, on 13,661 volume with 180,580 trades. The average volume for the last 3 months is 13,661 and the stock's 52-week low/high is $5.07/$18.20.

Sono-Tek Corporation (SOTK)

QualityStocks, MarketBeat, Zacks, SmallCapVoice, OTC Markets Group, The Bowser Report, Stock Guru, PCG Advisory, Marketbeat.com, Market Intelligence Center Alert and InvestorPlace reported earlier on Sono-Tek Corporation (SOTK), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Sono-Tek Corporation (NASDAQ: SOTK) is focused on the design and manufacture of ultrasonic coating systems that apply precise, thin film coatings to a range of components and parts for various markets.

The firm has its headquarters in Milton, New York and was incorporated in 1975, on March 21st by Harvey L. Berger. It serves consumers around the globe.

The company is involved in the design and manufacture of custom-engineered ultrasonic coating systems. It uses its ultrasonic spray coating technology to offer customized coating solutions to various manufacturing firms, allowing them to develop new products. It also offers patented generators and nozzles for manufacturers’ equipment. The company’s nozzles offer more uniform and thinner coatings with less liquid than a traditional spray nozzle. They use high frequency ultrasonic vibrations which atomize liquids into tiny drops that can be applied at low velocity to surfaces. Its other products include its OEM systems, fluxing systems, integrated coating systems and multi-axis coating systems.

The enterprise serves the research and development, industrial, medical, alternative energy, electronics/microelectronics markets, as well as the semiconductor, printed circuit board and nanomaterials industries. Its product applications include homeland security technologies like chemical vapor deposition systems and toxic gas sensors, while its medical product applications include joint replacements and cardiac stents. The enterprise distributes and markets its products via sales representatives and independent distributors.

The company recently reported its financial results for the first half of the 2021 fiscal year which show an increase in net sales, gross profits and net income. It’s focused on its strategic plan to offer higher value to its consumers, which will in turn create value for its shareholders.

Sono-Tek Corporation (SOTK), closed Monday's trading session at $5.8, off by 1.3605%, on 83,972 volume with 437 trades. The average volume for the last 3 months is 83,972 and the stock's 52-week low/high is $2.67/$6.74.

BioSig Technologies (BSGM)

QualityStocks, Broad Street, MarketBeat, Stock Commander, AwesomeStocks, OTCBB Journal, BUYINS.NET, SeeThruEquity Research, Fierce Analyst, Small Cap Firm, MarketClub Analysis, StockWireNews, StockMarketWatch, StocksEarning, WallstreetSurfers, Penny Stocks Finder, SizzlingStockPicks, PennyStock Tweets, Stockgoodies, Leading Penny Stocks, Penny Picks, Beacon Equity Research, Penny Stock Craze, The Wall Street Transcript, SuperStockTips, StockStreetWire, StockRockandRoll, Winston Small Cap, InvestorSoup, StockHideout, Stock Preacher, Damn Good Penny Picks, PennyStockLocks.com, Profitable Trader Authority, DreamTeamNetwork, BuzzStocks, Goldman Small Cap Research, Mega Stock Alerts, OTCtipReporter, ResearchOTC, Wall Street Resources, TradersPro, Street Picks, StocksImpossible, Stock News Now, PennyStockProphet, SECFilings.com News, Penny Pick Finders, Pumps and Dumps, PennyStockScholar, PennyStockLocks, Penny Stock General, Penny Stock Finder, Penny Stock 101 and Shiznit Stocks reported earlier on BioSig Technologies (BSGM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

BioSig Technologies Inc. (NASDAQ: BSGM) is a medical device firm that is focused on the development and commercialization of medical devices, with a focus on its biomedical signal processing platform.

The firm has its headquarters in Westport, Connecticut and was incorporated in 2009, on February 24th by Kenneth L. Londoner. It serves consumers in the United States.

The company is party to a strategic collaboration agreement with the Mayo Foundation for Medical Education and Research, which entails the development of a machine learning and AI software solution for its real-time electrogram electrophysiology PURE EP systems. It is also party to a research agreement with the University of Minnesota, which entails the development of new therapies for the treatment of sympathetic nervous system illnesses.

The enterprise’s products includes its signal processing platform known as the PURE EP system, which combines software and hardware to address challenges linked to signal acquisition. The precise uninterrupted real-time platform is a computerized system that has been designed to acquire, digitize, filter, calculate, display, record and store intracardiac and electrocardiographic signals for individuals who are undergoing electrophysiology procedures. The platform allows electrophysiologists to observe signals and analyze them immediately. The enterprise is also focused on improving intracardiac signal acquisition and diagnostic information for the procedures of ventricular tachycardia and atrial fibrillation.

The firm recently released its PURE EP system clinical data, which show a 75% overall improvement in intracardiac signal quality. Its CEO noted that the results validated the clinical importance of the firm’s technology as well as the firm’s position for continued growth and success. The firm is focused on advancing the field of electrophysiology and bioelectronics medicine.

BioSig Technologies (BSGM), closed Monday's trading session at $2.53, off by 1.1719%, on 84,087 volume with 920 trades. The average volume for the last 3 months is 84,073 and the stock's 52-week low/high is $2.35/$6.14.

Independence Contract Drilling (ICD)

MarketBeat, Zacks, Marketbeat.com, StockMarketWatch, TradersPro, StreetAuthority Daily, QualityStocks, InvestorsUnderground and AllPennyStocks reported earlier on Independence Contract Drilling (ICD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Independence Contract Drilling Inc. (NYSE: ICD) is engaged in the provision of contract drilling services for natural gas and oil producers that target unconventional resource plays in the U.S.

The firm has its headquarters in Houston, Texas and was incorporated in 2011, on November 4th by Byron A. Dunn and Philip A. Choyce. It operates as part of the support activities for the mining industry. The firm mainly serves consumers in the United States and has five companies in its corporate family.

The company is focused on its operations in unconventional resources plays situated in various regions in Midland and Houston, in the state of Texas. Its business is dependent on the level of production activity and exploration by natural gas and oil firms operating in the U.S., and particularly in areas where it advertises its contract drilling services.

The enterprise operates and owns a fleet made up of drilling rigs. Its ShaleDriller rigs have been designed to accelerate consumer production profiles and cash flows from their economically impactful and demanding gas and oil properties. Its rig fleet comprises of about 28 AC (alternating current) powered rigs. Of this number, about 23 are included in the enterprise’s marketed fleet. Its rigs primarily operate in the Eagle Ford Shale, the Haynesville Shale and the Permian Basin.

The firm recently reported their financial results for 2021’s second quarter, with its CEO noting that the firm is focused on increasing demand of all its rigs in its operating basins. This move will not only bring in additional revenue into the firm but also extend its consumer reach, which will have a positive effect on the company’s growth.

Independence Contract Drilling (ICD), closed Monday's trading session at $5.45, up 19.5175%, on 1,185,475 volume with 5,541 trades. The average volume for the last 3 months is 1.175M and the stock's 52-week low/high is $2.23/$7.97.

Compugen Ltd (CGEN)

Greenbackers, MarketClub Analysis, MarketBeat, OTC Picks, StockMarketWatch, The Street, TheStockAdvisor, Zacks, SmarTrend Newsletters, BUYINS.NET, StreetInsider, MicrocapVoice, TheStockAdvisors, Wealth Insider Alert, Penny Performers, InvestorPlace, Investor Guide, Forbes, TraderPower, CRWEPicks, Short Term Wealth, GorillaTrades, Market Wrap Daily, CoolPennyStocks, FeedBlitz, HotOTC, Momentum Traders, AllPennyStocks, Schaeffer's, SmallCapVoice, Standout Stocks, Stock Rich, Stock Traders Chat, Streetwise Reports, The Momentum Traders Network, The Online Investor, TradersPro, Trading Markets, Wall Street Greek and PennyOmega reported earlier on Compugen Ltd (CGEN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Compugen Ltd (NASDAQ: CGEN) is a clinical-stage therapeutic firm that is focused on researching, developing and commercializing therapeutic product candidates.

The firm has its headquarters in Holon, Israel and was incorporated in 1993, on February 10th by Amir Natan, Simchon Faigler and Eli Mintz. The firm serves consumers across the globe, with a focus on Europe, the United States and Israel.

The company is party to a collaboration agreement with the Johns Hopkins School of Medicine to assess novel T cell and myeloid checkpoint targets; another collaboration with Bristol-Myers Squibb which entails evaluating the tolerability and safety of COM701 in combination with the latter’s PD-1 immune checkpoint inhibitor, in individuals with advanced solid tumors; and another collaboration with Bayer Pharma AG, which entails researching, developing and commercializing antibody-based therapies. It is also party to a license agreement with AstraZeneca, which entails the development of multi-specific and bi-specific immune-oncology antibody products.

The enterprise’s therapeutic pipeline is made up of pre-clinical stage immune-oncology programs that are mainly focused on myeloid targets. On the other hand, its product pipeline comprises of a therapeutic antibody dubbed COM902, which targets TIGIT; and a therapeutic antibody that targets ILDR2 known as BAY 1905254, which is currently in a phase 1 clinical study evaluating its effectiveness in treating solid tumors. The enterprise also develops an anti-PVRIG antibody known as COM701, which is also undergoing a phase 1 clinical study testing its efficacy in treating solid tumors.

The company’s license agreement with AstraZeneca allows them to capitalize on bispecific products and broaden its product opportunities, which affords the company more opportunities for collaborations and investments.

Compugen Ltd (CGEN), closed Monday's trading session at $6.16, off by 3.1447%, on 868,428 volume with 5,919 trades. The average volume for the last 3 months is 816,842 and the stock's 52-week low/high is $5.76/$16.25.

Bearing Lithium Corp. (BLILF)

We reported earlier on Bearing Lithium Corp. (BLILF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Bearing Lithium Corp. is a lithium-focused mineral exploration and development company. Its principal asset is an 18 percent interest in the Maricunga Lithium Brine Project in Chile. The Maricunga Project represents one of the highest-grade lithium brine salars globally and the only pre-production project in Chile. OTCQB-listed, Bearing Lithium is headquartered in Vancouver, British Columbia.

The Maricunga Project represents one of the few projects at the development stage in Latin America. The Maricunga Project is one of only two brine projects held by publicly-traded companies at a Definitive Feasibility Study (DFS)-stage in the world. Greater than US$50 million has been invested in the Maricunga Project thus far. In addition, all expenditures through to the delivery of a DFS have been fully-funded by the earn-in joint-venture (JV) partner.

The Maricunga Lithium Brine Project is host to an NI 43-101 M&I resource of 2.1 million tonnes of lithium carbonate equivalent (LCE) at a grade of 1,170 mg/L lithium (Li). A 2019 DFS outlined production of 20,000 tpa LCE at a cash cost of US$3,772/t LCE over a 23-year mine life that generated an after-tax NPV (Net Present Value) 8 percent of US$908 million, IRR (Internal Rate of Return) of 21.0 percent, and 4.2-year payback including a 2-year ramp-up.

Bearing Lithium announced this past February that its joint venture (JV) company, Minera Salar Blanco S.A. (MSB), received environmental approval for the Maricunga project in the Atacama Region of northern Chile. Bearing Lithium holds an 18 percent interest in MSB, along with Lithium Power International (LPI-ASX) at 51 percent and a private Chilean company at 31 percent.

Bearing Lithium Corp. (BLILF), closed Monday's trading session at $0.3181, up 32.7131%, on 175,318 volume with 65 trades. The average volume for the last 3 months is 175,318 and the stock's 52-week low/high is $0.1004/$0.35.

Argentina Lithium & Energy Corp. (PNXLF)

We reported earlier on Argentina Lithium & Energy Corp. (PNXLF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Argentina Lithium & Energy Corp. focuses on the acquisition and exploration of natural resource properties in Argentina. The Company concentrates on acquiring high quality lithium projects in Argentina and advancing them towards production to meet the growing international demand from the battery sector. A natural resource company and OTCQB-listed, Argentina Lithium & Energy has its corporate office in Vancouver, British Columbia. The Company has its Argentina Exploration Office in Mendoza, Argentina.

Argentina Lithium & Energy has its Antofalla Project. This Project includes greater than14,000 hectares on the Salar de Antofalla in Salta Province, Argentina. This includes a 100 percent interest in roughly 9,000 hectares of mining claims in the north end of the Salar de Antofalla (Staked Properties) and an option agreement to earn a 100 percent interest in three additional properties totaling more than 5,300 hectares (Optioned Properties) positioned adjacent to the Staked Properties.

The Optioned Properties include two granted mine concessions and a third mine application. Terms of the option include cash payments totaling US$3,500,000 over 42 months but limited to only $500,000 in the first 18 months. Moreover, the option includes annual exploration expenditure commitments of $500,000 in year one, followed by $1.5M in year two, $2.0M in year 3, and $3.0M in year 4.

The Company has acquired a 100 percent interest in more than 25,500 hectares covering the Incahuasi Salar and basin in Catamarca province. This salar is within the “Lithium Triangle” of Argentina and Chile. It has characteristics prospective for lithium-rich brines. Initial sampling of near-surface brines returned up to 409mg/L lithium. Geophysical surveying indicates the potential for lithium-rich brines at depth.

Argentina Lithium & Energy is a member of the Grosso Group. The Grosso Group is a resource management group that has pioneered exploration in Argentina since 1993.

Argentina Lithium & Energy Corp. (PNXLF), closed Monday's trading session at $0.661, up 67.088%, on 1,369,570 volume with 672 trades. The average volume for the last 3 months is 1.37M and the stock's 52-week low/high is $0.04/$0.70.

SolarWindow Technologies, Inc. (WNDW)

Tip.us, QualityStocks, StockOodles, InvestorPlace, NetworkNewsWire, SmallCapVoice, TopPennyStockMovers, TradersPro, PoliticsAndMyPortfolio, Market Intelligence Center Alert, Stock Gumshoe, StocksToBuyNow, Winston Small Cap, The Online Investor, AllPennyStocks and Wealth Insider Alert reported earlier on SolarWindow Technologies, Inc. (WNDW), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

SolarWindow Technologies, Inc. is a developer of next generation, transparent, electricity-generating SolarWindow™ coatings. The Company is a developer of electricity-generating windows for tall towers and skyscrapers. SolarWindow™ utilizes organic materials dissolved into liquid, best for low-cost high-output manufacturing. SolarWindow Technologies is headquartered in Columbia, Maryland.

SolarWindow™ systems can undergo installation on the readily-available sizeable window glass surfaces on tall towers and skyscrapers. SolarWindow™ can be applied to the sides of tall towers, generating electricity using natural, shaded, and artificial light. The coatings produce electricity on see-through glass and flexible plastics with colored tints popular to skyscraper glass. Upon application to glass or plastics, the coatings convert passive windows and other materials into electricity generators under natural, artificial, low, shaded, and reflected light conditions.

SolarWindow™ technology has been independently validated to generate 50-times the power of a conventional rooftop solar system. Moreover, it realizes a one-year payback when modeled on a 50-story building. SolarWindow Technologies’ latest products will be engineered as transparent, tinted, flexible veneers, which installers can apply directly over top of existing windows on tall towers and skyscrapers. This expanded product line extends the Company’s market reach beyond new and replacement installations, to include windows now installed on the estimated five million commercial buildings built in the U.S. alone. 

SolarWindow Technologies is expanding product development to include applying its electricity-generating coatings onto flexible glass – as thin as a business card (only 0.1-millimeter-thick), which is flexible enough to be bent without breaking or cracking.

In November, SolarWindow Technologies announced the completion of a $25 million equity financing. Kalen Capital Corporation (KCC), the family office of Mr. Harmel S. Rayat, Founder and Chairman of the company, invested roughly $24.9 million in this round.

Mr. John Conklin, President and Chief Executive Officer of SolarWindow Technologies, said, “This capital infusion marks a historical inflection point for SolarWindow and our nearly 15,000 shareholders. With this capital in hand and a decade of research and development behind us, we can now purchase equipment and hire personnel required for manufacturing of electricity-generating glass, a brand-new form of electrification.”

SolarWindow Technologies, Inc. (WNDW), closed Monday's trading session at $6.23, up 27.1429%, on 347,606 volume with 1,166 trades. The average volume for the last 3 months is 347,606 and the stock's 52-week low/high is $3.19/$39.20.

NaturalShrimp Incorporated (SHMP)

QualityStocks, PennyPickGains, Pennystockmania, WallstreetSurfers, ThePennyPicks, SmallCapVoice, PoliticsAndMyPortfolio, Wall Street Mover and TopPennyStockMovers reported earlier on NaturalShrimp Incorporated (SHMP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

An AquaCulture Company, NaturalShrimp Incorporated produces naturally-grown shrimp in the United States and internationally. It is a leader in the “Closed-System Shrimp Farming” industry. In 2016-17, the Company introduced its patented vibrio suppression technology that is potentially disruptive to the entire shrimp farming industry. NaturalShrimp’s European partner has built a production facility in Medina del Campo, Spain. Expansion plans include domestic and worldwide production facilities and distribution channels. NaturalShrimp is based in Addison, Texas. It has production facilities located near San Antonio, Texas. The Company lists on the OTC Markets’ OTCQB.

NaturalShrimp systems can be located anywhere in the world to produce gourmet-grade Pacific white shrimp. NaturalShrimp has developed a technology to produce fresh, gourmet-grade shrimp reliably and economically in an indoor, re-circulating, saltwater facility. Its eco-friendly, bio-secure design does not rely on ocean water. It recreates the natural ocean environment allowing for high-density production that can be replicated anywhere around the world.

The water systems used in production are electrified systems that help to control ammonia and bacteria, killing 99 percent of all bacteria. Shrimp are brought into the facility at 28 days old and are raised until maturity. This happens around 14 weeks of age.

NaturalShrimp Incorporated (SHMP), closed Monday's trading session at $0.45199, up 36.9397%, on 6,794,519 volume with 1,394 trades. The average volume for the last 3 months is 6.784M and the stock's 52-week low/high is $0.104/$0.897.

BTU Metals Corp. (BTUMF)

We reported earlier on BTU Metals Corp. (BTUMF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

BTU Metals Corp. operates as a gold mining enterprise and focuses on the exploration and production of gold properties. It is a junior exploration company with its flagship Dixie Halo Project in Red Lake, Ontario. This Project is contiguous with Great Bear Resources Ltd. (GBR)’s flagship Dixie Project. BTU Metals lists on the OTC Markets and the Company is based in Vancouver, British Columbia.

The drill program is underway at the Dixie Halo Project. This Project is close to all the infrastructure needed to construct and operate a mine. There are highways and roads on the Property and powerlines and a natural gas line crossing the Property. In addition, there is plenty of water on the Dixie Halo Property.

The Dixie Halo Project consists of 19,723 hectares of highly prospective land in Red Lake, which is among the richest gold mining camps in the world. There was the discovery of the TNT Target in November of 2019 in drill holes 12 and 13, with significant intercepts of mineralization and alteration. The assay highlight is 44.3m of 1.14 percent CuEq with intervals containing as much as 5.56 percent CU, 99.6 g/t Ag, as well as 2 g/t Au.

Drill hole 13 assays reveal elevated copper, gold, and silver values. Geophysics, including ground IP (Induced Polarization) and resistivity, and also airborne VTEM (Versatile Time Domain Electromagnetic) are being used to ascertain the footprint of the target and to define drill targets. The target has a footprint of 200-500 meters east-west and at least 1,000 meters north-south.

The geological and geophysical data indicates the potential for polymetallic, gold-enriched “Volcanogenic Massive Sulphide” (VMS) mineralization. VMS style mineralization is one of the primary sources of copper and zinc production in Canada. Some VMS systems are enriched in gold and in some cases the contained gold is worth a substantial portion of the value of those deposits. BTU Metals has been building its overall property position aggressively since it first acquired land in the area in August of 2018.

BTU Metals previously provided an update on the Dixie Halo exploration work programs. Assay results from drill holes BTU-19-21 to 25, confirm the presence of a large alteration system at the TNT target. This alteration and associated mineralization that comprises varying amounts of pyrite and chalcopyrite, and also minor amounts of sphalerite, galena and molybdenite is traceable using the IP geophysical technique and electromagnetic methods. From drilling, this mineralization is known to extend throughout the TNT trend as outlined using IP for at least 2.2 km.

BTU Metals also announced an update on exploration activities and progress at its Dixie Halo Property near Red Lake, Ontario. Its exploration work remains on schedule with no disruption because of the Covid-19 crisis. The Company continues to operate under safe distancing protocols while monitoring the situation. It will take action as deemed necessary to safeguard its employees, contractors, and community. BTU Metals continues to pursue the TNT copper-silver-gold VMS-style target and the Dixie Creek target in its search for significant gold mineralization along the SW-NE structural trend across the wide-ranging 200 km2 Dixie Halo Property.

BTU Metals Corp. (BTUMF), closed Monday's trading session at $0.065, up 24.7601%, on 83,521 volume with 5 trades. The average volume for the last 3 months is 83,521 and the stock's 52-week low/high is $0.0499/$0.1944.

NutraLife BioSciences, Inc. (NLBS)

We reported earlier on NutraLife BioSciences, Inc. (NLBS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

NutraLife BioSciences, Inc. operates a multifaceted life sciences company. In 2010, it formed to manufacture and distribute private label and branded nutraceutical and wellness products. In 2017, the Company launched its hemp-based PCR products. The Company formerly went by the name NutraFuels, Inc. It changed its corporate name to NutraLife BioSciences, Inc. in March of 2019. NutraLife BioSciences is based in Coconut Creek, Florida and the Company lists on the OTC Markets.

NutraLife BioSciences was founded by Mr. Edgar Ward, its Chief Executive Officer, President and Director, to engage in the development, manufacturing and distribution of unique and effective nutritional products. Since then, the Company has developed into a successful developer, manufacturer and distributor of more than 50 nutraceutical, wellness, and CBD (cannabidiol) products. NutraLife BioSciences’ brand portfolio consists of NutraHempCBD, PCR Pure, and HerbalShield.

Via its subsidiaries, Precision Analytic Testing, Inc., and PhytoChem Technologies, Inc., NutraLife BioSciences provides bulk material analytical, identity, potency and purity testing of raw hemp, hemp cultivation, raw bulk material extraction, and processing. Its dedication is to bringing high quality, effective, beneficial nutrients to the marketplace.

NutraLife Biosciences launched a new line of phytocannabinoid-rich (PCR) skincare and nutraceutical products in 2019 under its in-house brand PCR Pure. NutraLife's new skincare debuted with a facial gel cleanser, a daytime face cream, a nighttime face cream, and also an eye cream. The Company stated that all of the PCR Pure skincare products are formulated using effective, naturally derived ingredients that nourish and rejuvenate the skin, and contain different natural plant extracts, including the hemp plant. All of PCR Pure’s products are free of parabens, sulfates, sulfites and suitable for daily use.

NutraLife Biosciences previously announced that it is converting its existing nutraceutical bottling manufacturing operation to produce sanitizer products. The Company has increased its scope of production in accordance with 21 CFR 211–Current Good Manufacturing Practices for Finished Pharmaceuticals. Additionally, it has been assigned its labeler code from the Food and Drug Administration (FDA) so as to operate as an Over-the-Counter (OTC) manufacturer. NutraLife BioSciences is taking all required steps to build up production while adhering to FDA guidelines for the production, packaging, labeling, and distribution of the sanitizer products.

NutraLife BioSciences, Inc. (NLBS), closed Monday's trading session at $0.12, up 20%, on 354,422 volume with 42 trades. The average volume for the last 3 months is 354,422 and the stock's 52-week low/high is $0.053/$0.18.

Mastech Digital, Inc. (MHH)

Wall Street Resources, StockMarketWatch, InvestorPlace, QualityStocks, Zacks, Barchart, BestOtc, CRWEFinance, CRWEPicks, CRWEWallStreet, DrStockPick, alert, PennyOmega, PennyToBuck, StockHotTips, TopPennyStockMovers and MarketBeat reported earlier on Mastech Digital, Inc. (MHH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Earnings Preview

Mastech Digital (MHH) was featured in a company-sponsored research note published by Sidoti & Company, LLC. The headline of the note reads, “Look For Accelerated Revenue Growth In 3Q:21 In Data & Analytics And IT Staffing, With EPS Expansion Muted By Strategic SG&A Initiatives; Maintain $31 Target Citing Attractive Valuation.”

Click here to access the full report.

Mastech Digital is a leading provider of Digital Transformation IT Services. The Company offers Data Management and Analytics Solutions, Digital Learning, and IT Staffing Services with a Digital First approach. A minority-owned enterprise, Mastech Digital is headquartered in Pittsburgh, PA with offices across the U.S., Canada, EMEA, India and ASEAN. Please visit www.mastechdigital.com.  

Mastech Digital, Inc. (MHH), closed Monday's trading session at $17.52, up 0.574053%, on 5,812 volume with 108 trades. The average volume for the last 3 months is 5,812 and the stock's 52-week low/high is $14.00/$20.65.

The QualityStocks Company Corner

FingerMotion Inc. (OTCQX: FNGR)

The QualityStocks Daily Newsletter would like to spotlight FingerMotion Inc. (OTCQX: FNGR) .

FingerMotion (OTCQX: FNGR), a big data communications technology innovator, is focusing its new big data platform, Sapientus, on China’s insurance market. Speaking during an August corporate update conference call, FingerMotion CEO Martin Shen acknowledged that the company has also considered eventually focusing its big data platform on other industries beyond insurance and in markets beyond China’s borders. However, Shen indicated that the company will stay focused on its immediate purpose before expanding its reach. To view the full article, visit https://ibn.fm/wnM1Q.

FingerMotion Inc. (OTCQX: FNGR) is an evolving technological company with core competencies in mobile payment and recharge platform solutions in China. FingerMotion is in the process of developing additional value-added technologies to market to users.

Founded in 2016, FingerMotion’s goal is to serve over a billion users in the Chinese market and expand its model to other regional markets. The company has offices in Hong Kong, Shanghai and New York City.

Current Offerings

FingerMotion is analyzing and transforming mobile data to improve the lifestyle of the public through technology and innovation. The company’s current offerings include:

  • Telecommunications Products and Services – FingerMotion’s proprietary universal exchange platform, ‘PigeonHole Integration System (PIS)’, offers seamless integration between telecom operators and online stores. The service platform’s offerings include top up and recharge, data plan, mobile phone, loyalty points redemption and subscription plans. The platform offers reliable and secure transactions, real-time reconciliation, simple integration for partners and efficient settlements.
  • SMS and MMS Services – The integrated platform is registered as FingerMotion’s IP in China and provides a robust back-end control panel for corporate partners to manage their own messaging settings. FingerMotion’s clients range from insurance to financial industries, ecommerce firms, airlines and more. The platform offers competitive pricing for partners and provides quick and efficient review to meet timely marketing initiatives.
  • Big Data Insights – FingerMotion brings Big Data-enabled insurance solutions through its Big Data Insights arm, Sapientus. The company’s strategic partnerships with the largest Chinese telecommunications giants allow access to uncover behavior insights through geolocation and mobile data usage. Its Big Data offerings include risk scoring, precise marketing, simplified underwriting and customized products.
  • Rich Communication Services (RCS) – FingerMotion’s RCS platform will be a proprietary business messaging solution that enables businesses and brands to communicate their services to customers via 5G infrastructure. The company expects its RCS platform to offer a better user experience, more efficiency and cost-effectiveness when compared to other solutions.

Telecommunications and Insurtech Markets

The global telecommunications market was valued at $1.74 trillion in 2019 and is expected to grow at a CAGR of 5% from 2020 to 2027. The steady increase is expected to be driven by the adoption of 5G and the increased popularity of Internet of Things (IoT) applications.

The Chinese telecom market was valued at $254.1 billion in 2017 and is also constantly expanding. The current Chinese telecom market is dominated by three mobile operators – China Mobile, China Unicom and China Telecom, which together are responsible for around 1.6 billion active subscribers (https://ibn.fm/zfwy9).

In addition, the insurtech (insurance technology) market was valued at $2.72 billion globally in 2020 and is expected to grow at a CAGR of 48.8% from 2021 to 2028. The large increase is attributed to the rising use of technology solutions for everyday activities like acquiring insurance coverage (https://ibn.fm/TGo7D).

Through its proprietary platforms and technologies, FingerMotion is uniquely positioned to capitalize on the telecom and insurtech markets’ growth and opportunities.

Management Team

Martin J. Shen is the Chief Executive Officer of FingerMotion Inc. He has over 15 years of experience in senior management roles within entrepreneurial startups and large multinational corporations. He has acquired a wide range of corporate management, financial oversight and operation administration expertise through these roles. In his most recent role, he founded Imperial Distributors (formerly known as AP Martin Pharmaceutical Supplies Ltd.), establishing the company as the preferred choice for distributional support to regional pharmacies throughout Western Canada. Before founding Imperial, Mr. Shen served as the Chief Operating Officer and Chief Financial Officer at Wales and Son Industrial (formerly Weir Minerals), a firm specializing in global delivery and support for mining slurry equipment. He began his career at PricewaterhouseCoopers in Vancouver, with work tours in the tax department in Singapore and the tax audit and advisory group in Hong Kong. Mr. Shen is a U.S. Certified Public Accountant and holds a Bachelor of Science from the University of British Columbia.

Lee Yew Hon is the company’s Chief Financial Officer. From 2006 until November 2020, he was the Chief Financial Officer of Cubinet Interactive Group of Companies, and he also took on the Chief Operating Officer role in 2011. During his tenure, he was instrumental in leading Cubinet and building teams across the Southeast Asia region, setting up financial processes within a short time. Mr. Lee spearheaded the growth of Cubinet to other regions, including Europe, the Middle East and Russia. He received his diploma from Tunku Abdul Rahman College in 1996. He is a Chartered Accountant, a member of the Malaysia Institute of Accountants (MIA) and an Associate Member of the Chartered Institute of Management Accountants, UK (ACMA).

Li Li is the Senior Vice President of FingerMotion. She recently served as Advisor to Shenzhen WuYiKa Technology Co. Ltd., a comprehensive service platform dedicated to online service distribution and payment. The company has become a fast and efficient provider of new media marketing solutions for the mobile internet. She has held high-level management positions with multiple industry names, including Hangzhou JiuYue Information Technology Co. Ltd. and Hangzhou LingXuan Information Technology. Ms. Li started her career in 2004, founding Shanghai ChuangYeZZ Network Technology Co. Ltd. and serving as its Vice President. With the close cooperation of local operators, the company launched SMS, MMS, WAP, mobile JAVA games, Hunan Satellite TV e-magazine and other wireless internet services to meet the rapid development of wireless internet and application requirements. She received her degree from Nanjing Academy of Engineering.

FingerMotion Inc. (FNGR), closed Monday's trading session at $6.61, up 5.76%, on 64,208 volume with 205 trades. The average volume for the last 3 months is 64,208 and the stock's 52-week low/high is $3.22/$17.00.

Recent News

Nemaura Medical Inc. (NASDAQ: NMRD)

The QualityStocks Daily Newsletter would like to spotlight Nemaura Medical Inc. (NASDAQ: NMRD).

  • Nemaura Medical is a medical technology company focused on developing non-invasive wearable diagnostic devices
  • The company recently announced the beta launch of MiBoKo, a combined application and non-invasive glucose sensor designed to help users track their metabolic scores
  • US diabetes-related healthcare expenditures totalled $760 billion in 2019 alone, equating to an annual spend of over $9,000 per diabetic patient

Nemaura Medical (NASDAQ: NMRD) is a cutting-edge medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs. The company recently carried out the beta launch of MiBoKo, a new proprietary metabolic health program designed to utilize a non-invasive glucose sensor and an AI based mobile application (https://ibn.fm/FsV8g).

Nemaura Medical Inc. (NASDAQ: NMRD) is a medical technology company developing affordable diagnostic and digital tools for chronic disease management. Its flagship product, sugarBEAT®, is a wearable, non-invasive and flexible Continuous Glucose Monitor (CGM) designed to help people with diabetes and prediabetes manage their glucose levels. Insulin users can adjunctively use sugarBEAT when calibrated with a finger-stick glucose reading.

sugarBEAT consists of a daily disposable adhesive skin patch connected to a rechargeable transmitter with a smartphone app displaying glucose readings at five-minute intervals for periods of up to 24 hours. One of the great advantages of the product, apart from the fact that users no longer need to draw blood samples or prick their fingers, is that a person can wear the CGM patch on whatever day they choose. Existing CGM devices must be implanted under the skin. Wearable disposability is a unique feature of sugarBEAT and a world first, opening up vast potential for changing the way people manage their chronic disease conditions. sugarBEAT received CE mark clearance in May 2019, allowing it to be marketed and sold within the European Union as a Class 2b Medical Device. The company submitted a premarket approval (PMA) application to the U.S. Food and Drug Administration in 2020 which is currently under review.

Founded in 2011, Nemaura set out to develop a single platform technology to measure blood markers at the surface of the skin. Since then, the company has evolved with the creation of wearable technologies and digital health care solutions that encourage and empower people to take charge of their own health and well-being. Nemaura’s skin surface blood monitoring technology has allowed the company to create additional products, which are in the pipeline, such as Lactate Monitoring.

Technologies

Digital Solutions for Weight Loss and Potential Reversal of Type 2 Diabetes

This is a digital program that comes with more than a decade of clinical evidence demonstrating excellent efficacy. The company has combined this with its glucose-monitoring platform to bring a product to market to help people with diabetes manage their condition and potentially reverse Type 2 diabetes.

Glucose Monitoring Solutions for Diabetes Prevention and Reversal

Over 420 million people worldwide are living with diabetes, and prediabetes cases total almost three times that number. Undoubtedly, diabetes is an urgent global health crisis. Combining clinical research with patient-friendly technology, Nemaura’s sugarBEAT product delivers a non-invasive, affordable and flexible method of blood glucose tracking for improved diabetes management.

Continuous Lactate Monitoring for Athletic Performance (Non-Medical)

Lactic acid is a key performance indicator for the body and a guide to how well muscles react to long term exertion and recovery. Well-trained athletes and those who regularly engage in sports are very efficient at faster lactate ‘recycling’ for extra energy (ATP). Nemaura expects to launch its lactate sensor to the sports and personal training market in 2022.

Continuous Lactate Monitoring in Disease State (Medical)

An increase in blood lactate levels is also a marker of critical disease states. Recent publications have indicated the presence of elevated lactate levels in patients with COVID-19 infection. Nemaura has developed a lactate sensor that is being integrated into the company’s platform, which will be submitted for regulatory clearance upon completion of requisite clinical studies.

Continuous Temperature Monitoring for Viral Infection Detection and Disease Progression

A person’s body temperature says a lot about their health. Several diseases, including COVID-19, are characterized by an increase in body temperature, so temperature monitoring is a vital tool in the detection, diagnosis and prevention of the spread of disease. Nemaura is expecting to submit this adaptation of the device for regulatory clearance in 2022.

Market Opportunity

Obesity and diabetes are two of the major drivers of the current chronic disease epidemic. According to the International Diabetes Federation, there are more than 463 million people living with diabetes worldwide. In the U.S., about 28,000 people are diagnosed with diabetes every week, and more than 34 million suffer from diabetes. Another 88 million Americans have prediabetes. Other industrialized countries show similar numbers based on their populations. In the U.K., 4.8 million people have diabetes, with another diagnosed every two minutes. In Germany, 9.5 million have diabetes, with almost half estimated to be undiagnosed and so at greater risk.

On average, employers and insurers spend more than $9,000 annually on health care for an employee with diabetes, compared to $1,600 annually for a healthy employee. In the U.S. alone, more than $760 billion was spent on diabetes-related health care expenditures during 2019. Nemaura is positioned at the intersection of the global Type 2 diabetes market that is expected to reach nearly $59 billion by 2025, the $50-plus billion prediabetic market, and the wearable health-tech sector for weight loss and wellness applications forecast to hit $60 billion by 2023.

Management Team

Dr. Faz Chowdhury has been CEO and chairman of the board of Nemaura Medical since 2013. He has more than 20 years of experience in the pharmaceutical and medical devices industry, taking products from concept to commercial launch. He is sole inventor on more than 100 granted and pending patents and has authored textbook chapters on nano-biosciences for Wiley and Elsevier. He holds a master’s degree in microsystems and nanotechnology from Cranfield University, and a doctorate from the University of Oxford in nano-medicine and drug delivery.

Justin Mclarney is CFO at Nemaura. He most recently was the Senior Director, International Finance at Lands’ End Inc. He also worked for Office Depot as Senior Director of Finance for the largest business unit within the European group. Prior to that, he spent more than 10 years in practice, the majority of which was with Ernst & Young LLP.

Dr. Fred Schaebsdau is Vice President of Strategy & Strategic Alliances at Nemaura. He has more than 15 years of executive experience in the CGM, blood glucose monitoring and insulin delivery industries, including time with Abbott Diabetes Care, as General Manager of Dexcom Germany and at Roche Diabetes Care, where he was Senior Vice-President, Head of Global Strategy and Business Development. The firm he founded is the exclusive distributor in Europe, the Middle East and Africa of UniStrip®, the world’s first generic blood glucose test strip. He is licensed to practice medicine in the U.S. and Germany.

David Scott is Director of Commercial Development and Licensing at Nemaura. He is a trained chemist with over 35 years of experience in the pharmaceutical industry, including deal brokering, marketing, strategic planning, finance, business development and acquisitions. He has also provided licensing training for a number of multinational pharma companies and training organizations and is the author of best-selling report Scrip’s Practical Guide to Pharmaceutical Licensing.

Nemaura Medical Inc. (NASDAQ: NMRD), closed Monday's trading session at $5.92, up 1.5437%, on 22,367 volume with 269 trades. The average volume for the last 3 months is 22,209 and the stock's 52-week low/high is $3.3013/$17.40.

Recent News

Vivos Therapeutics Inc. (NASDAQ: VVOS)

The QualityStocks Daily Newsletter would like to spotlight Vivos Therapeutics Inc. (NASDAQ: VVOS).

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from mild to moderate obstructive sleep apnea (“OSA”) and snoring, and Candid Care Co., a digital platform for oral healthcare, today announced a new collaboration. The partnership will seek to provide patients with a comprehensive, whole-mouth solution to diagnose and treat OSA in adult patients and provide orthodontic treatment from the same provider network. To view the full press release, visit https://ibn.fm/wQJZb

Headquartered in Denver, Colorado, Vivos Therapeutics Inc. (NASDAQ: VVOS) is an emerging global leader in the treatment of mild-to-moderate obstructive sleep apnea (OSA), a debilitating condition affecting nearly 1 billion people worldwide. The company utilizes proprietary, ground-breaking technology, a proven go-to-market strategy, and a powerful executive team dedicated to changing the face of health care by helping people of all ages properly breathe and sleep.

At the core of Vivos’ mission to rid the world of mild-to-moderate OSA is the Vivos System®, a revolutionary clinical breakthrough in the treatment of mild-to-moderate sleep apnea often caused by craniofacial anatomy development. The Vivos System® multidisciplinary treatment protocol involves collaboration between physicians, specially-trained dentists who have completed advanced training in craniofacial sleep medicine, and other ancillary health care providers.

In support of its growth strategy, Vivos has established contract manufacturing facilities in the U.S., Canada and Asia.

Market & Technology Overview

Craniofacial developmental deficiencies, such as underdeveloped upper and lower jaws, are among the leading causes of OSA. According to a 2019 analysis from researchers at the University of California, San Diego, an estimated 81 million adults in North and South America suffer from moderate to severe OSA. The United States has the highest amount of these patients, with approximately 54 million adults affected, according to the report.

Registered with the FDA as a Specification Developer, Vivos develops and markets a number of oral appliances. Its technology represents the first non-surgical, non-invasive and cost-effective treatment for the estimated hundreds of millions of people globally who suffer from mild-to-moderate OSA.

Vivos integrates its specially designed, customized appliances into a patient-specific, multi-disciplinary clinical protocol, giving trained dental and medical providers the tools and roadmap needed to address certain craniofacial conditions that studies have shown to be associated with sleep-disordered breathing—including mild-to-moderate OSA.

The system’s treatment protocol involves collaboration between physicians, specially trained dentists who have received advanced training in craniofacial sleep medicine, and additional health care providers. Vivos-trained clinicians can be found in almost every major city in the U.S. and in many countries throughout the world. The company’s oral appliances have shown to be effective in over 15,000 patients successfully treated worldwide by approximately 1,200 trained dentists.

A New Paradigm in Sleep Medicine

Vivos’ proprietary system poses the potential to be the biggest breakthrough in the treatment of mild-to-moderate OSA since CPAP.

The Vivos System has been specifically designed to promote the proper growth and development of the hard and soft tissues surrounding and comprising the oral cavity, nasal cavity, upper and lower jaws, and other tissues which together form and shape the upper airway. As these areas develop more fully using the Vivos System, a patient’s airway typically widens and expands, enabling them to breathe properly through their nose. With a more open and less obstructed airway, and easier nocturnal breathing, the symptoms of SDB tend to diminish over time, and patients often report they no longer suffer from the adverse effects of SDB or OSA.

Use of the Vivos System is variable and case dependent, but typically recommended to be worn daily for 12 to 16 hours starting in the early evening and continuing overnight. The total treatment time typically ranges from 12 to 24 months, with 18 months being the approximate mean treatment time.

Biomimetic Oral Appliance

Vivos Therapeutics believes that the Vivos System technology represents the first non-surgical, non-invasive and cost-effective treatment for people with mild-to-moderate OSA.

Combining technologies and protocols that can alter the size, shape and position of the tissues of a patient’s upper airway, the Vivos System opens airway space and can significantly reduce symptoms and conditions associated with mild-to-moderate OSA.

The Vivos System treatment is typically less than $10,000 and is often reimbursable by medical insurance as an out-of-network benefit.

A potentially serious medical problem with an alternative treatment therapy available in the dental office.

Hard and soft tissues of the craniofacial complex can be non-surgically enhanced using the proprietary Vivos® System devices and clinical protocols.

Leadership

R. Kirk Huntsman – CEO, Director
With experience in strategic development, technology acquisition and product planning, key talent recruitment, and target market prioritization, Huntsman brings a broad vision paired with leadership and strategic planning skills. He has significant start-up experience in a diverse range of market sectors, including medical devices, dental management, dental practice valuations and transitions, multi-location retail, financial and capital formation, consulting, outsourced services, imports and exports (China), medical services, and software and technology.

Dr. Dave Singh – Founder, Director
A doctor three times over in dental medicine, craniofacial development, and orthodontics, Dr. Singh was educated primarily in England and has lectured in North America, Europe, Asia, and Africa. The Global Summits Institute recently named Dr. Singh as one of the Top 100 Doctors in Dentistry.

Vivos Therapeutics Inc. (NASDAQ: VVOS), closed Monday's trading session at $3.88, up 9.2958%, on 208,900 volume with 1,517 trades. The average volume for the last 3 months is 208,900 and the stock's 52-week low/high is $2.61/$14.41.

Recent News

Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF)

The QualityStocks Daily Newsletter would like to spotlight Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF).

Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF)a propriety Software as a Service (“SaaS”) technology company delivering mobile live dealer technology to online gaming operators globally, has reported more than $24.2 million in player betting turnover in the first half of October. That amount is a 1,500% increase over the $1.6 million reported for the entire month of September. “Daily player betting turnover is approximately $1.6 million per day, up from about $53,500 per day for the month of September. We are extremely excited about our month over month growth,” said Playgon Games CEO Darcy Krogh in the press release. “We knew our proprietary technology was innovative, however the reception we have received from our partners and clients has been unparalleled. This is noticeable from the player wagering activity, which has increased to 305,000 bets for the half month of October compared to 132,000 bets for the entire month of September. We are witnessing at least 100% growth across all of our key indicators.” To view the full press release, visit https://ibn.fm/eJ6c3  

Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF) is a SaaS technology company focused on developing and licensing digital content for the growing global iGaming market. The company provides a multi-tenant gateway that allows online operators the ability to offer their customers innovative iGaming software solutions. Its current software platform includes Live Dealer Casino, E-Table Games and Daily Fantasy Sports. Seamless integration at the operator level allows customer access without requiring the sharing of any sensitive customer data. Playgon games run on any browser and any device as fast and secure as a native app, without requiring any app store download. All that’s needed is a stable internet connection. The gaming experience is identical across all mobile devices. As a true business-to-business digital content provider, the company’s products are scalable turnkey solutions for online casinos, sportsbook operators, location-based operators, media groups, and big database companies.

Playgon’s proprietary technology provides digital games for online gambling sites and mobile device apps, with the company licensing its mobile live-dealer technology to online gaming operators worldwide. Playgon combines high definition live streaming dealers with state-of-the-art augmented reality betting to provide the most authentic casino experience, live from Las Vegas. Playgon’s mobile platform features popular table games, all optimized for one-handed play on mobile devices.

The COVID-19 pandemic has accelerated an already existing shift away from location-based casinos to online gambling. At the same time, the proliferation of mobile devices has provided players with new access to betting. A younger, tech-savvy consumer demographic is driving adoption of digital gaming globally. To meet this demand, Playgon has launched a studio with 10 gaming tables from which its live dealer streaming video originates. The company’s platform is live with multiple online casino operators through four aggregator clients in South Africa and Europe, and commitments are coming in from more.

Playgon plans to expand the studio to 25 tables in the near term and is working to establish a U.S. strategy. The company will continue to expand licensing of its live dealer games to iGaming operators worldwide under a SaaS license agreement. As a B2B software supplier, Playgon avoids player acquisition costs.

Games

Live Dealer Casino

Playgon offers the first and only Live Dealer Casino streaming live from Las Vegas. The company brings cutting-edge handheld features and functionality to the mobile generation of gaming enthusiasts who demand a world-class gaming experience on all devices. Playgon’s Blackjack delivers the look and feel of location-based casino tables with features providing players with the most unique user experience. The company’s true-to-life Roulette offers players a clear and uninterrupted view of the dealer, wheel, ball, bets, results, trends and statistics. Players can strategize, place multiple bets, track results and review trends without ever losing focus of the game.

Playgon’s traditional Baccarat and proprietary Tiger Bonus Baccarat™ prove their worth by not only recognizing the need for a prominent product, but by adding elements which separate them from the pack without removing their authenticity. The games mix advances in technology with the traditional game attributes that have resonated and captivated players for hundreds of years.

eTable Games

To lead the rise of mobile-first gaming, Playgon developed a user experience perfected for one-handed play. Providing this next evolution in gaming technology ensures the company’s client operators loyalty from existing customers and is a powerful strategy to attract and retain new players. Playgon’s VEGAS LOUNGE™ brings together an innovative mix of games, technology and gameplay that offers players an authentic experience and real Las Vegas casino fun every time, everywhere.

Daily Fantasy Sports

Playgon’s Daily Fantasy Sports (DFS) are a subset of fantasy sport games which typically target a younger demographic. DFS provides iGaming operators a turnkey fantasy sports platform that can quickly go to market, integrate with the operator’s existing operations and services, and be customized to match and enhance the operator’s brand. The platform is mobile and desktop friendly, built for regulated market environments, and allows operators to monetize users through a network of shared liquidity.

Market Outlook

Online casinos and sports betting sites/apps are increasingly adding market share to traditional location-based casinos. This trend is only expected to accelerate as millennials reach their peak earning years and Gen Z youth begin to complete their education and move into careers. These generations are completely comfortable with online recreation, as well as tech like digital wallets and digital gameplay that underpins Playgon Games. The company has been described as “Netflix + Vegas, all in one.”

The online gambling market is slated to reach a value of $127.3 billion by 2027, according to Grand View Research, with much of the growth expected from the U.S. and Asia. Even Europe, the most mature gaming market, is expected to grow at a rate of 20-25 percent year over year. The current global online Live Casino TAM is estimated at about $6 billion annually, and revenue is forecast to reach more than $8 billion by 2023 and more than $13 billion by 2027.

Management Team

Darcy Krogh is CEO of Playgon Games. He is a veteran of the iGaming industry with over 20 years of experience. In 1999, he co-founded Chartwell Technology Inc., which pioneered the development of browser-based digital content for the iGaming industry. After that company was sold to Amaya Gaming Group, he served as VP Business Development with Amaya. In 2016, he started Playgon Games (formally Global Daily Fantasy Sports Inc.) as President and CEO. His experience in the online gaming industry includes sales and marketing, relationship management, corporate finance, M&A, and strategic corporate development.

Guido Ganschow is President of Playgon Interactive. He has more than 12 years of experience in creating real-time Live Dealer technology and platforms and was the co-founder and Creative Director for a Macau-based casino consortium. Between 2008 and 2014, he successfully created and established Live Dealer platform businesses in Asia and Europe, and executed commercial partnerships, sales, and integration of the Live Dealer solution with major global gaming brands, including Ho Gaming Group, Chartwell Technology and Amaya Gaming Group.

Steve Baker is COO of Playgon. He is a former VP Operations for Shaw Communications, where he was directly involved in video streaming, home entertainment, new products, sales and M&A. He oversaw revenue growth from $300 million to $2.8 billion and employee growth from 350 to 13,000. He has broad experience and a proven record in development and implementation of cost effective and efficient growth strategies transitioning businesses from development to operations.

Harry Nijjar is CFO of Playgon Games. He is currently a Managing Director with Malaspina Consultants Inc. and provides CFO and strategic financial advisory services to his clients across many industries. This experience has allowed him to help his clients successfully navigate the regulatory and financial environments within which they operate. Mr. Nijjar holds a CPA-CMA designation from the Chartered Professional Accountants of British Columbia.

Playgon Games Inc. (PLGNF), closed Monday's trading session at $0.2375, up 3.7118%, on 23,621 volume with 15 trades. The average volume for the last 3 months is 23,621 and the stock's 52-week low/high is $0.197/$1.32.

Recent News

Asia Broadband Inc. (OTC: AABB)

The QualityStocks Daily Newsletter would like to spotlight Asia Broadband Inc. (AABB).

Data released by researchers show that one of the two metallic asteroids floating in Earth’s vicinity could contain precious minerals worth more than $11 trillion. The researchers expect that the asteroid may have more cobalt, nickel and iron than the global metal reserves combined. These metal-rich asteroids have been dubbed 2016 ED85 and 1986 DA. The findings from the study’s analysis were reported in the “Planetary Science” journal, with researchers noting that the two asteroids are potential targets for asteroid mining in the future. The popularity of space mining has increased in the scientific community as experts believe it could offer cost-effective metals for a lunar-based colony, which would help extend humanity’s reach in space exploration. Additionally, the presence of a cosmic mine would eliminate the need to have building materials flown from Earth to space. If space mining from these asteroids becomes a reality, it would be a significant way to supplement the minerals extracted on Earth by companies such as Asia Broadband Inc. (OTC: AABB), thereby ensuring that the demand for these minerals is met for decades to come.

Asia Broadband Inc. (OTC: AABB) is a resource company focused on the production, supply and sale of precious and base metals, primarily to Asian markets.

The company utilizes its specific geographic expertise, experience and extensive industry contacts to facilitate its innovative distribution process from the production and supply of precious and base metals in Mexico to client sales networks in Asia. This vertically integrated approach to sales transactions differentiates Asia Broadband from its competitors in the mining space.

Development Program in Colima, Mexico

In October 2020, Asia Broadband announced its acquisition of a high potential mineral property in the state of Colima, Mexico. Per the press release, previous geophysics and groundwork have revealed strong indications of significant mineralization in multiple sectors of the property.

The company recently began the construction of exploration and development facilities and infrastructure roads on its Colima property, and plans are underway to extend previous geophysics and groundwork on the property. In January 2021, Asia Broadband announced its allocation of $10 million for the initial development program, with the aim of accelerating operations at the Colima site toward production.

Positioned in a major gold-iron-copper production area, the company’s Colima property is situated approximately 25 kilometers east of the Pena Colorada mine in Minatitlan, Mexico. It is advantageously located, with direct access to main Highway #3, and the property also has an essential natural water supply.

AABB Gold Token

In December 2020, Asia Broadband announced its entry into a definitive development agreement with Core State Holdings Corp., a digital assets and crypto wallet creator, to produce a white label gold-backed cryptocurrency coin. The AABB Gold token is an ERC-20 token being developed on the Ethereum blockchain.

In a February 2021 news release, the company provided a development update on the cryptocurrency token, noting that Core State Holdings Corp. “is continuing to modify the set-up and move through the final stages of testing of the iOS and Android AABB Wallet applications, including the implementation of an application interface to allow users to see the real-time exchange rate of gold that backs the price of the AABB Gold token set at one-tenth of a gram or approximately $5.80 USD.”

Core State Holdings Corp. has also continued to enhance www.AABBGoldToken.com, which the company notes will be the go-to knowledge base for all information concerning the soon-to-be launched AABB Wallet and AABB Gold token.

AABB’s primary goal for the token is to become a worldwide standard of exchange – secured and trusted with gold backing – by expanding circulation and targeting large population and high growth markets globally, including China and East Asia.

Asia Broadband Inc. (AABB), closed Monday's trading session at $0.11195, up 0.67446%, on 12,835,140 volume with 801 trades. The average volume for the last 3 months is 12.835M and the stock's 52-week low/high is $0.0026/$0.659.

Recent News

Infobird Co., Ltd (NASDAQ: IFBD)

The QualityStocks Daily Newsletter would like to spotlight Infobird Co., Ltd (NASDAQ: IFBD).

  • Infobird, a leading software-as-a-service (SaaS) provider of AI powered customer engagement solutions in China, is one of the few companies in China that has built a customer engagement SaaS on a cloud-native architecture, and has remained consistent with innovation and offering unique customer engagement solutions 
  • The company’s products and services ride on the backbone of their self-developed, cloud-computing structure, robotic-process-automation (“RPA”) machine learning, patented Voice over Internet Protocol (“VoIP”), no-code development platform, and other powerful technologies.
  • Infobird is also pioneering a new product that is differentiated from standard private domain traffic tools, allowing enterprises with a large customer base to cost-effectively personalize and automate their services

Infobird (NASDAQ: IFBD) has consistently innovated and offered unique customer-engagement solutions. The company has made a name for itself by leveraging proprietary next-generation technology, a product of years of research and development (“R&D”). This has allowed it to stamp its position as a leader in the Software-as-a-Service (“SaaS”) industry, particularly in the Chinese market.

Infobird Co., Ltd (NASDAQ: IFBD) is a software-as-a-service (SaaS) provider of AI-powered customer engagement solutions in China. Infobird leverages a self-developed cloud computing structure, AI and machine learning capabilities, patented Voice over Internet Protocol (VoIP) application technologies, a no-code development platform and in-depth industry expertise to best serve its growing client base.

Founded in October 2001, Infobird empowers clients with value-driven business solutions designed to increase revenue, reduce costs and enhance service quality and customer satisfaction. The company currently specializes in corporate clients in finance and a broad array of ancillary industries.

Infobird is headquartered in Beijing, China, and began trading on the Nasdaq Capital Market on April 20, 2021, following an initial public offering of 6.25 million ordinary shares at a public offering price of $4.00 per share, before underwriting discounts and commissions.

Product Offering

Infobird’s flagship customer engagement software can handle both AI Customer Engagement and AI Salesforce Management.

  • AI Customer Engagement
    • Intelligent Omni-Channel Customer Service – This offering allows clients to connect with their customers anytime and anywhere through a comprehensive suite of cloud-based tools.
    • Cloud Call Center – This service puts Infobird’s years of technical and operational experience to work for clients, with options including intelligent IVR technology, call monitoring, routing strategy and ticketing systems, all supported by multi-dimensional data reports.
    • Intelligent Telemarketing – Infobird’s AI bots can help clients navigate “never-ending lists” of potential customers, filter out the most promising leads and increase the working efficiency of agents, keeping agents focused on high-value tasks.
    • AI Voice Chatbot and AI Text Chatbot – This technology allows clients to create human-like interactions offering 24/7 availability and multi-round dialogue capabilities, decreasing labor costs by up to 80% while greatly improving efficiency.
  • AI Salesforce Management
    • Intelligent Quality Inspection – Infobird’s platform aims to improve quality inspection rates and service levels through the use of real-time smart monitoring with comprehensive coverage.
    • Intelligent Training – Interactive training programs allow clients to ensure and continuously improve the performance level of their agents, lessening the impact of high turnover rates common throughout the customer service industry.

Infobird’s client base includes roughly 10,000 paid user accounts representing 358 customers in the industries of finance, education, public services, consumer products and health care – as reported on June 30, 2020.

Market Outlook

Cloud infrastructure services spending in China increased by 32% ($39.9 billion) in the fourth quarter of 2020. For all of 2020, total services grew to $142 billion, up from the reported $107 billion in 2019. This growth can be attributed to rising demand for cloud infrastructure over physical software solutions (https://ibn.fm/rHZUh). China is the second-largest market for cloud infrastructure solutions after the U.S., accounting for roughly 14% of the global industry.

Likewise, SaaS has demonstrated considerable growth potential in recent years. In 2020, the SaaS industry in China was valued at $3.3 billion, representing an increase of 43.5% over 2019, as companies continue to leverage artificial intelligence and Big Data technologies to increase efficiencies and promote expansion.

As one of the leading and longest standing providers of domestic SaaS solutions and with a comprehensive portfolio of intelligent, customizable and scalable solutions, Infobird is uniquely positioned to capitalize on the market’s expansion and resulting opportunities for corporate growth.

Management Team

Yimin Wu is the CEO and Founder of Infobird. He has served as the Chairman of the board of directors and Chief Executive Officer of the company since it was founded. From August 1990 to March 1993, Mr. Wu was a software engineer for the Software Center of Tsinghua University and was sent to the U.S. to co-develop the HP_UX operating system at HP Inc. From April 1993 to May 2000, he served as the general manager for Beijing Jing Zhou Computers Co. Ltd., a company responsible for marketing and developing interactive voice response systems. From July 2000 to October 2001, Mr. Wu was the general manager for Beijing Jing Zhou Rong Hua Internet Technology Co. Ltd, a company responsible for developing middleware for call center establishments. He received a bachelor’s degree and a master’s degree in computer sciences from Tsinghua University.

Hsiaochien Tseng is the EVP of Infobird and has held the title since January 2020. From March 2010 to September 2018, he served as a sales director for the Credit Card Center of China Guangfa Bank, where he was responsible for integrating and managing online and offline sales channels, establishing overall and regional sales strategies and creating training systems to increase the client base. From October 2018 to January 2020, Mr. Tseng served as SVP of Hua Tuo Digital Technology Group Co. Ltd., a financial information technology company. He received a bachelor’s degree in information management from Fu Jen Catholic University and a master’s degree in business administration from San Diego State University.

Chunhsiang Chen is the VP of Infobird, a position he has held since April 2012. From June 1990 to February 1993, he served as an advisory programmer of International Business Machine Corp. (IBM). During that time, he participated in the design and development of the Multiple Protocol Transport Network. From February 1993 to September 1996, Mr. Chen served as an associate professor in the Information Education Department of National Taiwan Normal University. He founded GenNet Technology Co. Ltd., an information technology company, in 1993 and served as the president until joining Infobird in 2012. Mr. Chen has a bachelor’s degree in computer sciences from the National Chiao Tung University and a master’s degree and doctoral degree in computer sciences from Northwestern University.

Lianfang Zhou is the CFO of Infobird and has been with the company for over 10 years. From September 2004 to July 2008, she served as the head of accounting at Beijing Saishuo Technology Co. Ltd., a software development company specializing in port services. From August 2008 to December 2009, Mrs. Zhou served as the head of accounting for Beijing Lianhe Lida Investment Co. Ltd., a property management services company. She holds an intermediate accounting qualification certificate issued by the Ministry of Finance of the PRC. Mrs. Zhou also has a bachelor’s degree in accounting from the Renmin University of China.

Infobird Co., Ltd (IFBD), closed Monday's trading session at $2.12, off by 0.469484%, on 35,860 volume with 224 trades. The average volume for the last 3 months is 35,817 and the stock's 52-week low/high is $2.045/$11.25.

Recent News

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF)

The QualityStocks Daily Newsletter would like to spotlight LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF).

LQwD Fintech (TSX.V: LQWD) (OTC: LQWDF), a financial technology company focused on creating enterprise-grade infrastructure to drive Bitcoin adoption, recently established network computers (routing nodes) to deploy Bitcoin into payment channels on the company’s Lightning Network platform. “This milestone was the first stage of the Lightning Network platform becoming fully operational, as it provided infrastructure, solutions and liquidity to support the network’s development and fee earning potential,” reads a recent article discussing the strategic move. “LQwD’s Lightning Network is a layer-2 payment protocol built on top of the Bitcoin blockchain. It is composed of nodes running the proprietary software. These are then connected to other nodes through payment channels that allow the payment to find the recipient. For payments to go through, enough Bitcoin must exist in the payment channel. As a Lightning Network Services Provider (‘LSP’), LQwD stakes Bitcoin on routing nodes to ensure the functionality of the network where fees can be earned for forwarding the payments.” To view the full article, visit https://ccw.fm/EsW56

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) is a financial technology company focused on creating enterprise-grade infrastructure to drive bitcoin adoption.

LQwD FinTech’s mission is to develop institutional-grade services that support the Lightning Network and drive improved functionality, transaction capability, user adoption and utility, and scaling of bitcoin. LQwD is also securing a substantial position in bitcoin as an operating asset and will use its holdings to establish nodes and payment channels on the Lightning Network.

The Lightning Network is a second-layer protocol, sitting above the bitcoin blockchain, intended to facilitate faster micro-transactions and lower fees on bitcoin transactions, thus allowing mass adoption of bitcoin.

LQwD expects the Lightning Network to eclipse the patchwork of legacy financial networks that are used to move value today. The company’s software will make migration from legacy networks onto the Lightning Network easy and seamless. By onboarding more financial service providers, LQwD intends to grow the value of the Lightning Network.

The company, formerly known as Interlapse Technologies Corp., is harnessing new payment rails built on top of the bitcoin blockchain that are capable of beyond visa-level transaction volumes and backed by bitcoin, the strongest and most well-known cryptocurrency. These new rails, enabled by the Bitcoin Lightning Network, open a vast opportunity and market segment for digital payments and financial services on a global scale. LQwD aims to leverage its position as a public company to enhance trust in its products and services, and leverage its shares as currency for acquisitions, roll-up and growth, as well as to attract and retain top industry talent.

Product

The Lightning Network is a solution to massively scale the use of bitcoin for microtransactions globally, dramatically improving upon fees, as well as providing instant settlement times. The Lightning Network has experienced explosive growth and is expected to continue with the trend as usage increases. Well-known companies, such as Twitter and Square, have expressed their enthusiasm to incorporate Lightning Network into their platforms. The Lightning Network is scalable, global, open, inclusive, permissionless and decentralized. It is made up of nodes connected via payment channels, and enables off-chain, instantaneous and cheap payments at scale.

Upon launch of LQwD’s Lightning Network platform-as-a-service, users will be able to leverage the Lightning Network infrastructure to send payments instantly, securely and inexpensively anywhere in the world. Companies and service providers will be able to conduct Lightning Network transactions in bitcoin by integrating LQwD’s infrastructure with their business or web property. Connected businesses will be able to easily deploy, monitor and manage LQwD’s Lightning Network nodes with no or low-level technical knowledge required. The company fully expects Lightning Network to be a force for global change and to become the monetary exchange network of the future.

The Lightning Network, which is already built, functioning and growing, will advance bitcoin from a store-of-value to a global monetary network through payment utility. The company expects the Lightning Network will propel the growing number of active blockchain wallets to new heights, by increasing bitcoin’s scalability and lowering its fees for users. For coming generations, everything from wealth to experiences will be acquired and transacted virtually, and LQwD sees the Lightning Network as an enabling technology that can bring bitcoin to hundreds of millions of new users across the globe.

Market Outlook

Forbes in August 2021 noted that “private investors are funding companies that are building the infrastructure that will support future growth of crypto and digital assets,” and called public companies building cryptocurrency infrastructure “the hottest part of the crypto market.” While the first wave of investor interest in crypto firms was directed at companies catering to retail investors, investors have now shifted their attention to infrastructure builders, like LQwD FinTech. Forbes did not put an estimated value on the crypto infrastructure market but pointed out that large-scale adoption of cryptocurrencies will only happen when infrastructure is in place to support it. The larger digital payments market, of which crypto payments are a small fraction, is growing at more than 14 percent annually and is forecast to hit $154 billion by 2025.

Management Team

Shone Anstey is co-founder, chairman and CEO at LQwD FinTech. He has 20 years of experience in building complex technologies and has acted as technology lead for an industrial bitcoin mine and bitcoin mining pool. He is a Certified Cryptocurrency Investigator, and an advisor to the British Columbia Securities Commission. He is also co-founder of BIGG Digital Assets (OTCQX: BBKCF) and took that company public in 2017.

Barry MacNeil is CFO at LQwD FinTech. He is a member of the Chartered Professional Accountants of British Columbia and has more than 30 years of management and accounting experience with public companies and in private practice. His previous positions include director of both public companies and nonprofits, as well as Chief Financial Officer and Corporate Controller.

Albert Szmigielski is co-founder and CTO at LQwD FinTech. He was formerly the Head of Research and Chief Blockchain Engineer at Blockchain Intelligence Group and VP Research at CipherTrace. He holds a B.Sc. in Computing Science from Simon Fraser University, and a Master of Science in Digital Currencies and Blockchain Technologies from the University of Nicosia, Cyprus.

LQwD FinTech Corp. (LQWDF), closed Monday's trading session at $0.356, off by 3.7838%, on 30,031 volume with 18 trades. The average volume for the last 3 months is 30,031 and the stock's 52-week low/high is $0.1213/$4.00.

Recent News

Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF)

The QualityStocks Daily Newsletter would like to spotlight Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF).

A recently conducted study has found that while the risk of SARS-CoV-2 breakthrough infection was low in vaccinated individuals with substance-use disorders, it was higher than the risk of vaccinated individuals who don’t suffer from substance use disorders. The research was conducted by researchers at the National Institute on Drug Abuse and was reported in “World Psychiatry.” Researchers from Case Western Reserve University also took part in the study. Existing research shows that substance-abuse disorders have a strong link to the workings of the mind, and companies such as Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) are focused on developing psychedelic medicines that address such problems from the root to help patients.

Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (“MINDCURE”) is a diversified life sciences company at the forefront of the mental health industry. The company is currently developing digital therapeutics and researching psychedelic compounds, while innovating and commercializing new ways to promote healing and improve mental health.

MINDCURE’s research and digital therapeutics technology supports access to safe, science-based, evidence-backed psychedelic-assisted therapies globally. With hundreds of millions of people suffering from mental illnesses worldwide and an estimated $1 trillion in lost productivity per year, psychedelics offer promising alternatives for healing. This medical need has been amplified by the COVID-19 pandemic. According to the Centers for Disease Control and Prevention, 40 percent of U.S. adults reported struggling with substance abuse or mental health issues during the pandemic.

MINDCURE is uniquely positioned to address these medical needs. By concentrating on both technology and research, the company is focusing on near-term revenue generation, targeting a longer-term, blue sky horizon and hedging against regulatory unknowns with a scalable, adaptive model. MINDCURE’s software-as-a-service (SaaS) platform, iSTRYM, scales globally and services every psychedelic medicine without the capital-intensive drag of clinic scale-out costs. The company plans to first enter the market for psychedelic-assisted psychotherapy, then to move into the larger fields of technologically undisrupted psychotherapy and psychiatry.

Technology

Digital therapeutics include health interventions delivered through a smart device to induce a behavioral change in the patient. The global market is focused on simplifying behavioral change and empowering consumers to take charge of their own health. iSTRYM is the company’s AI-driven software platform that enables personalized and quantified outcomes in psychedelic therapy. The SaaS platform modernizes care, taking it from manual to digital and bringing better treatment outcomes for patients and therapists while lowering costs for insurers.

iSTRYM offers clinicians direct access to global, science-backed, evidence-based protocols, integration plans, insights into client journeys, and real-time assessments for personalized care. Patients access the platform on their smart devices, enjoying transparency into their wellness journeys, personalized care resources, and optimized relationships with their practitioners. The minimal viable product (MVP) of the software is being launched in Q3 2021. MINDCURE targets a Q1-Q2 2022 commercial product launch.

Research

In June 2021, the company announced it had completed the first stage of manufacturing pharmaceutical-grade synthetic ibogaine to be used in clinical research. In July, MINDCURE announced it had filed U.S. Provisional Patent applications for the company’s first full synthetic routes to create ibogaine. The company’s pharmaceutical grade ibogaine would provide researchers access to a sustainable, high-quality, reliable, and consistent supply of the psychedelic drug.

The company is also actively researching ibogaine as a potential treatment for Traumatic Brain Injury and related conditions. Preliminary data show the drug may also have promise as a treatment for neuropathic pain and migraines. In addition, research indicates ibogaine may help repair and rewire the brain’s neural pathways, making it potentially useful in the treatment of addictions.

Market Outlook

MINDCURE actively develops technology, conducts research, and distributes products in several market spaces. The global market for digital therapeutics is projected to grow to $6.9 billion by 2025, from an estimated $2.1 billion in 2020. In North American alone, the market is forecast to reach $5 billion by 2025.

The market for treatment of drug, alcohol and other addictions is estimated to be worth $38.2 billion in 2021, with a forecast CAGR of 5.2 percent for the next several years. The global market for the treatment of neuropathic pain is forecast to account for $9 billion by 2027, while drug treatment for migraines is expected to have a value of $2.1 billion by 2025.

Management Team

Kelsey Ramsden is President and CEO of MINDCURE. She has 15 years of experience founding, scaling, and operating innovative companies across Canada and the Caribbean. She has built multiple eight-figure businesses and twice been named Canada’s Top Female Entrepreneur. She holds a seat on the Entrepreneurship Council for the University of Western Ontario, where she is also a faculty member. She has an MBA from the Richard Ivey School of Business at the University of Western Ontario.

Dr. Joel Raskin is the Chief Medical Officer at MINDCURE. He is a psychiatrist and academic with 20 years international pharmaceutical experience in neuroscience drug development, lifecycle preparation, launch and commercialization with Eli Lilly & Co., where, as Senior Director, he led the medical affairs team for Alzheimer’s disease diagnostics and therapeutics. He earned his medical degree from the University of Toronto and is a Fellow of the Royal College of Physicians and Surgeons of Canada in Psychiatry.

Tarik Lebbadi is the COO at MINDCURE. He has more than 13 years of international operational experience. Before joining the company, he led the medical division of Johnson & Johnson in Morocco. He holds a BA in mathematics and computer science from Ripon College and an MBA from IESE Business School in Barcelona, Spain.

Geoff Belair is the CTO at MINDCURE. He has 30 years of experience working in highly regulated industries, including fintech and banking. He was the senior architect and creator of the Integration Services Team at banking solutions company Fincentric Corporation. Before joining MINDCURE he was Vice President of Information Technology at Westland Insurance.

Michael Wolfe, CPA CA, is MINDCURE’s CFO. He has 30 years of experience in finance, accounting, private equity, and business valuation. He was previously CFO of Baylin Technologies Inc., as well as CFO of several mid-market Canadian companies, including Masstech Group Inc. He was General Partner at VenGrowth Capital Partners Inc. He holds an MBA from McMaster University and a BA in business and economics from the University of Western Ontario.

Daniel Herrera is Vice President of Growth & Strategic Partnerships at MINDCURE. He is a former pharmaceutical executive with extensive experience in highly regulated industries. He is experienced with medical affairs, product development and product licensing, negotiations with public and private payers, GPOs, and pharmacy buyers, as well as strategic partnerships resulting in high-value M&A transactions. He is a graduate of McGill University and the University of Montreal and holds an MBA from the John Molson School of Business at Concordia University.

Mind Cure Health Inc. (OTCQX: MCURF), closed Monday's trading session at $0.238, off by 2.6585%, on 222,150 volume with 58 trades. The average volume for the last 3 months is 222,150 and the stock's 52-week low/high is $0.223/$0.8584.

Recent News

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF)

The QualityStocks Daily Newsletter would like to spotlight Avricore Health Inc. (OTCQB: AVCRF).

  • Avricore, through its HealthTab(TM) flagship offering, is bringing health diagnosis and treatment closer to people
  • The point-of-care testing market, which Avricore is part of, shows incredible potential for growth in the coming years
  • Strategic investments and critical partnerships with other key players in the industry have allowed Avricore to stand out among its competitors
  • This has also enabled the company to create value for stakeholders and better outcomes for patients

The point-of-care testing market is projected to be valued at $50.6 billion by 2025, up from $29.5 billion in 2020. This will represent a compounded annual growth rate (“CAGR”) of 11.4% during the forecast period, mainly fueled by the rising cases of infectious diseases, technological advancements of point-of-care devices, along with an increase in investments by key companies and players in the industry (https://ibn.fm/qn479). One such player is Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF), a company at the forefront of moving pharmacy forward. Described as a heath diagnostics technology innovator focused on acquiring and developing early-stage technologies, Avricore has been at the frontage of offering a turnkey point-of-care testing platform that, so far, has created value for stakeholders and better outcomes for its patients.

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward. Through its flagship offering, HealthTab™ (a wholly owned subsidiary), the company aims to make actionable health information more accessible to everyone by creating the world’s largest network of rapid testing devices in community pharmacies.

HealthTab

HealthTab is a turnkey point-of-care testing solution that effectively turns pharmacies into diagnostic hubs (sometimes known as ‘Community Diagnostic Centers’, or CDCs) and connects them on a single, cloud-based platform.

The HealthTab network model is unlike anything in pharmacy today. It gives knowledgeable and trusted pharmacists a greater role in primary care delivery and empowers patients to take more control of their health. It also reduces costs and waiting times while providing many potential revenue streams, including equipment leasing & consumables, direct access testing, disease prevention & management programs, sponsored health programs, decentralized clinical trials, real world data (RWD) sets and third-party app integration through API.

Agreement with Shoppers Drug Mart

In June 2021, Avricore signed a Master Agreement with select Shoppers Drug Mart pharmacies to pilot the HealthTab platform. This agreement gives patients access to point-of-care blood screening and health-data management for potential risks relating to diabetes and cardiovascular conditions using HealthTab-integrated Afinion 2™ analyzers provided by Abbott Rapid Diagnostics.

Avricore is the first pharmacy solutions provider to partner with Abbott (NYSE: ABT), the global health care company and diagnostics leader in Canada. In May 2021, the company signed a supplier distribution agreement to expand the distribution of Abbott’s Afinion 2 and associated tests for diabetes and heart disease screening in community pharmacies in Canada. This agreement includes valuable HbA1c testing, a critical marker for the screening and management of diabetes.

Near Term Goals

Near term goals for Avricore include expansion into more pharmacies across Canada, followed soon after by entering the U.S. and UK markets. The company has made significant strides in testing and developing its technology and is moving into the commercialization stage.

Strategic partnerships like those with Abbott and select Shoppers Drug Mart pharmacies advance Avricore closer to becoming an incredibly dominant player in the community diagnostics space. The company aims to make actionable health information more accessible for everyone by creating the world’s largest rapid testing network in pharmacies.

Market Outlook

In 2020, the global point-of-care testing (POCT) market was valued at $34.49 billion and expected to expand at a compound annual growth rate (CAGR) of 9.4 percent to reach a projected $81.37 billion by 2028. This upsurge is expected to be driven largely by increased demand for screening and management tools for chronic diseases, as well as rapidly assessing infectious diseases such as COVID-19.

The accessibility of POCT has been an increasing priority of the world’s leading health organizations and experts. Pharmacies are ideal ‘hubs’ within the community to offer patients better access to the numbers they need to know for preventing or treating conditions such as diabetes and heart disease or the timely diagnosis of infection.

Management Team

Avricore’s leadership team brings a diverse portfolio of expertise across the health care and biotech industries, as well as technology, finance and communications. Together, they share a common vision of moving pharmacy forward and have positioned the company for significant future growth and expansion.

Hector Bremner is the CEO of Avricore. He has over 15 years of senior and executive experience across various industries, including international trade, natural gas, marketing and communications. He owned and operated TOUCH Marketing, a boutique marketing and communications firm based in Vancouver, from 2007 to 2013. Mr. Bremner has also served as the executive assistant to the Deputy Premier and Minister of Natural Gas Development, Responsible for Housing, as well as the Minister of International Trade and Minister of Small Business. In 2015, he joined Vancouver’s Pace Group Communications as VP of Public Affairs.

David Hall is the Chairman and a Director of Avricore. His leadership spans five different companies. He is currently the Chairman of RepliCel Life Sciences and a member of the boards of TrichoScience Innovations, AdvantageBC and Providence Health Care Research Institute. Mr. Hall also served as Chairman of Perceptronix Medical Inc.; Chief Financial Officer, Secretary & Treasurer of Angiotech Pharmaceuticals Inc.; President & Director at Newcastle Resources Ltd.; and Chairman for LifeSciences British Columbia.

Kiki Smith is Avricore’s CFO. She has over 20 years of experience assisting private and public companies in the roles of accountant, corporate controller and CFO in mining, oil & gas, real estate, high technology, food production and investment fund management. She currently provides consulting services in M&A, financial reporting and regulatory compliance to several public and private companies across several investment sectors. Ms. Smith is a member of the Chartered Professional Accountants of British Columbia and has a bachelor’s degree in economics from the University of British Columbia.

Rodger Seccombe is the Head of Avricore’s HealthTab division and the co-founder and former CEO of HealthTab Inc. Mr. Seccombe has over 20 years of experience launching and running companies in software, health care technology and clean energy. He is a recognized industry expert in direct-to-consumer and point-of-care testing technology. In 2006, he joined the start-up team at Canadian Bioenergy Corporation and helped pioneer the development of the renewable fuel industry in Canada. Before HealthTab, he designed and developed cloud-based informatics systems currently in use by some of the world’s leading medical laboratories and instrument manufacturers.

Avricore Health Inc. (OTCQB: AVCRF), closed Monday's trading session at $0.1217, off by 4.9961%, on 51,087 volume with 8 trades. The average volume for the last 3 months is 51,087 and the stock's 52-week low/high is $0.06/$0.48562.

Recent News

Hero Technologies Inc. (OTC: HENC)

The QualityStocks Daily Newsletter would like to spotlight Hero Technologies Inc. (OTC: HENC).

  • License prequalification should give HENC shareholders great confidence in strategic Michigan business plan
  • Hero Technologies, Blackbox now beginning the last step in process of obtaining licensing approval
  • Once full funding has been reached, BlackBox anticipates being shovel ready within two months

In its ongoing commitment to position itself as a multistate operator in the cannabis sector, Hero Technologies (OTC: HENC) is focused on becoming fully licensed in Michigan. As part of that process, the company recently announced that Blackbox Systems and Technologies LLC, a HENC subsidiary, has fulfilled the requirements for step 1 prequalification approval for a Class C Medicinal Use cannabis license in Michigan; Blackbox also received step 1 prequalification approval for a Class C Adult-Use cannabis license (https://ibn.fm/x5UjK).

Hero Technologies Inc. (OTC: HENC) is a cannabis company with a vertically integrated business model and plan that includes cannabis genetic engineering, farmland for medical and recreational cannabis cultivation, production licenses, distribution licenses, consumer packaging, retail operations and dispensaries that make the organization a multi-state operator (MSO).

The company was founded in 2004 and is headquartered in Dover, Delaware.

Portfolio

The company holds the majority stake in BlackBox Systems and Technologies LLC, an aeroponic cannabis cultivation firm focused on providing optimal conditions to enhance photosynthesis and cultivation. Hero Technologies is planning expansion in cultivation and dispensary operations in Colorado through wholly owned subsidiary Mile High Green LLC, while expansion in Massachusetts is planned through another wholly owned subsidiary, MassCannabis LLC.

Hero Technologies also owns and operates HighlyRelaxing.com under Highly Relaxing LLC and recently acquired the assets of V Brokers LLC, now operating as Veteran Hemp Co. at VeteranHempCo.com.

BlackBox Systems and Technologies LLC

BlackBox Systems and Technologies LLC markets a proprietary cannabis aeroponic cultivation system designed for the large-scale production of top-shelf cannabis products. BlackBox offers the optimal conditions to enhance photosynthesis and promote the cultivation of large flowering plants. The system’s dry room, process room and secure storage were designed for precise control through each phase of the cannabis lifecycle. Weekly harvests are achieved using 13 separate BlackBox systems in independent modules.

The system provides a series of key benefits, including:

  • High-pressure nutrient delivery, with no nutrient or PH deficiencies
  • Sterile, 100% nutrient solution
  • Drain to Waste (no reuse of wastewater)
  • Low water usage (1 gallon per plant per day)
  • Constant PH and EC in reservoirs
  • Modular design (1 to 100 pods in any configuration)
  • Innovative proprietary engineering
  • Minimal cleanup
  • Media-less growing, suspended in the air, with no media waste
  • No pesticides

Highly Relaxing LLC

Highly Relaxing LLC is an emerging Henderson, Nevada-based operation dedicated to providing customers with honestly labeled, high-quality hemp-derived CBD products. Its current offerings include a topical CBD cream that provides localized relief from potential discomfort.

Veteran Hemp Co.

Veteran Hemp Co.’s mission is to provide a quality, consistent and delicious product for Americans looking to enjoy the hemp smoking experience. Its product is brought in by only the finest farming operations delivering the best genetics. Veteran Hemp Co. has its own custom harvest plans, drying facilities and all of the logistics that fall between. Veteran Hemp Co. prides itself on being a veteran-approved company.

Market Outlook

The global legal cannabis market is anticipated to reach $84 billion by 2028, expanding at a CAGR of 14.3% from 2021 to 2028. The driving factor for this forecast expansion is the increasingly widespread legalization of cannabis for medical and recreational use. Recreational use accounted for 60.3% of industry revenue in 2020.

North America provided the largest revenue share in the cannabis market, accounting for 91.1% of the global market in 2020. Due to the early legalization of medical and recreational cannabis in the region, the customer pool has increased exponentially (https://nnw.fm/snpHh).

The global CBD market was valued at $2.8 billion in 2020 and is expected to grow at a CAGR of 21.2% and reach $13.4 billion by 2028. North America is considered the most progressive region for cannabis and its derived products, with the highest number of CBD companies being based on the continent. The B2B (business to business) segment dominates the CBD industry, accounting for the largest revenue share at 59.6% in 2020 (https://nnw.fm/cGxXQ).

With its vertically integrated business model and development into a multi-state operator across multiple sectors of the cannabis industry, Hero Technologies is uniquely positioned to capitalize on the fast-growing market and the growing number of opportunities emerging as a result of legalization and increased popularity among consumers.

Management Team

Gina Serkasevich, CPA, CMA, is the Chief Executive Officer, Treasurer and Secretary of the Hero Technologies. She previously worked for Holloman Corporation as its Director of Finance beginning in June 2012 and was appointed Chief Financial Officer of Holloman Energy Corporation in August 2014. She has more than 30 years of domestic and international corporate accounting and finance experience. She served as U.S. Controller for EFLO Energy Inc., a company focused on the acquisition, exploration and development of oil and gas assets in North America. Prior to 2012, Ms. Serkasevich worked in the oil and gas tanker transportation industry as a Regional Financial Manager for AET Inc. Limited (2011-2012), as a Financial Consultant for OSG Ship Management Inc. (2009-2011) and as a Financial Controller/CFO for Stena Bulk LLC (1998-2008). During her 11-year tenure at Stena Bulk LLC, she established the financial, accounting and reporting requirements for its new joint ventures and tanker pools with Sonanagol USA and held the Company Secretary position on both of those companies’ boards of directors.

Dan McCarthy is the company’s Corporate Development Manager. He has spent more than 12 years in the institutional investment community, holding various investment banking and private equity executive roles. Thus far, he has been a part of over $1 billion in transactional value ranging from debt and equity to acquisitions and diversities throughout his career. Mr. McCarthy’s most recent role was Managing Director at Petro Capital, a Dallas-based private equity and investment bank. He began his career working for a private international consulting firm based in Washington, D.C., helping corporations and funds expand into non-G7 countries utilizing World Bank financing. He is also a graduate of the University of Kansas School of Business and completed the Mergers and Acquisitions program at the New York Institute of Finance.

James Rowland is Hero Technologies’ Marketing Advisor and an expert in marketing and e-commerce. He has held many high-level marketing and business-related roles. He is the Founder and current CEO of PerfectCheckout.com and the current Business Development Specialist at Fulfillment.com. Mr. Rowland has held multiple high-level positions throughout his career, which have provided him with the experience needed to bring success-backed marketing leadership skills to his current role with the company.

Hero Technologies Inc. (HENC), closed Monday's trading session at $0.078, off by 1.2658%, on 148,591 volume with 19 trades. The average volume for the last 3 months is 148,591 and the stock's 52-week low/high is $0.024/$0.3174.

Recent News

Friendable Inc. (FDBL)

The QualityStocks Daily Newsletter would like to spotlight Friendable Inc. (FDBL).

  • “Double Down” October is an exclusive promotion to help with fan promotion while providing artists additional incentives to promote the Fan Pass brand
  • The top three artists in October will also receive monetary prizes for first, second, and third place – $500, $250, and $150, respectively
  • Friendable is focused on a 90-day growth and development strategy, taking the Company into the New Year

For the entire month of October, Friendable (OTC: FDBL), a mobile technology and marketing company focused on developing and identifying products, services, and brand opportunities that present mass-market potential and scalability, has announced a unique opportunity for artists on the Fan Pass Live Streaming artist platform. Named “Double Down” October, the contest gives artists on the platform the opportunity to double the revenue they earn for the entire month. The top three revenue-earning artists for the month will receive additional monetary prizes (https://ibn.fm/Hkh9s).

Friendable Inc. (FDBL) is a mobile technology and marketing company focused on connecting and engaging users through its proprietary mobile and desktop applications. Launched July 24, 2020, the company’s flagship offering is designed to help artists engage with their fans around the world and earn revenue while doing so. The livestreaming platform supports artists at all levels, providing exclusive artist content ‘Channels’, LIVE event streaming, promotional support, fan subscriptions and custom merchandise designs, all of which serve as revenue streams for each artist.

With Fan Pass, artists can offer exclusive content channels to their fans, who can use their smartphones to gain access to their favorite artists, as well as an all-access pass to all artists on the platform. Additionally, the Fan Pass team will deploy social broadcasters to capture exclusive VIP experiences, interviews and behind-the-scenes content featuring their favorite artists – all available to fan subscribers on a free trial basis. Subscriptions are billed monthly at $3.99, or about the cost of downloading a couple of songs, and VIP experiences are available at a fraction of the cost of traditional face-to-face meetups.

Friendable Inc. was founded by Robert A. Rositano Jr. and Dean Rositano, two brothers with over 27 years of experience working together on technology-related ventures.

The Fan Pass Mobile & Desktop App

Friendable Inc. launched its Fan Pass platform as a solution for artists and their fans as the COVID-19 pandemic and the associated shutdown have continued to severely hamstring the entertainment industry as a whole. Through Fan Pass, the company aims to reach artists at all levels looking to alter their touring schedules to include ‘Virtual Touring’, new revenue sources and innovative fan engagement opportunities that are expected to become permanent fixtures of artists’ touring routines moving forward.

Fan Pass creates an ecosystem that embraces fans of all kinds, feeding diehard followers and developing lasting connections with more casual supporters. Through the app, qualified artists are provided with a custom designed, exclusive ’Fan Pass Channel’ where they can invite fans and social followers from anywhere around the world to join in chats and live events – allowing fans to experience all there is to see of an artist in one place. Artists earn revenue from monthly fan subscribers, merchandise sales, tickets sold for virtual streaming events and generally from all content views or impressions on their channels. All content views and sales of every kind are reported to each artist through their dashboards, including real-time payout and earnings information.

Fan Pass’ exclusive ‘All Access VIP’ option provides fans with access to content, such as:

  • Live performances or online concerts
  • Backstage meetups before, during or after events
  • Livestreams of studio sessions
  • Behind-the-scenes footage of music video and photo shoots
  • Special interviews and one-on-one videos
  • Streams highlighting the artists’ daily lives

The Fan Pass platform is extremely intuitive, bringing each artist through a streamlined onboarding process, including building out artist ‘Channels’, scheduling LIVE events and designing special edition merchandise to be offered solely through exclusive Fan Pass merchandise stores.

“With the global pandemic disrupting the entertainment industry in such a profound way, artists have had to look to digital distribution and live virtual performances in order to maintain any earning opportunities. Fan Pass and our team are determined to provide solutions and support to all artists, their fans and the industry in general. We are excited about the opportunity we have to shape the future of virtual entertainment, revenue generation and artist/fan engagement,” Robert A. Rositano Jr., CEO of Friendable Inc., stated in a news release.

Market Opportunity

Artists rely heavily on revenue streams that are not often seen by those without intimate industry knowledge. When it comes to traditional performances, the sale of VIP/backstage or meet & greet passes to boost revenue can often become the majority of the artist’s annual tour revenue. Data provided by one of the company’s original entertainment partners, The Kluger Agency (TKA), suggests that as much as 18-23% of artists’ annual tour revenue has historically been derived from these VIP experiences.

The World Economic Forum reports that, in 2020, the six-month-plus disappearance of live music concerts is estimated to have cost “the industry more than $10 billion in sponsorships,” and individual artists are feeling the loss the most. Fan Pass is helping to bridge this gap, providing more affordable virtual VIP experiences that can be offered simultaneously to fans around the world.

While it’s free for artists to join, Fan Pass leverages a monthly subscription model paid by fans to generate revenues. These revenues are shared with all channel artists. In exchange for its platform features, live streaming tools, bandwidth, processing and handling, Fan Pass earns platform fees on each separately ticketed event, as well as splits with each artist on subscriber fees and merchandise designed and sold on the platform.

The U.S. video streaming industry is expected to hit $7.08 billion in value in 2021, with an estimated 100 million internet users watching online video content every day, according to data from Livestream.com. The same report suggests that 45% of live video audiences would pay for exclusive, on-demand video from a favorite team, speaker or performer. Through Fan Pass, Friendable Inc. is uniquely positioned to capitalize on this opportunity.

Friendable App

The company’s second application, Friendable, is an all-inclusive platform where users can meet, chat and date. The app has exceeded 1.5 million total downloads, with over 900,000 historical registered users and more than 580,000 historical user profiles.

Friendable Inc.’s Next Phase of Growth

To facilitate its next phase of growth, Friendable Inc. is seeking an additional $1 million in equity investment, with a follow-on funding that meets or exceeds $5 million. The company intends to utilize its relationships to secure the lowest cost of capital available, as these funds will drive technology advancements, increase head count, fund marketing initiatives and secure additional celebrity talent aimed at bringing larger fan audiences to each released event. These initiatives will assist in building recurring monthly (fan) subscribers, effectively generating recurring monthly revenue for each artist, as well. The next phase of growth is expected to play a key role in accelerating the company’s download and conversion of data for subscription revenue and merchandise sales.

The company’s primary goal is to establish Fan Pass as a premier brand and mobile platform dedicated to connecting and engaging users around the world. In support of this goal, it has entered into a partnership with Brightcove targeting OTT platform expansion, including leaders such as iOS, Android, Apple TV, Android TV, Roku and WWW.

In the highly competitive video streaming market, Friendable Inc. has tapped into an unmet demand from today’s ever-present ‘omni-users’ for constant contact with celebrities and influencers. Via Fan Pass, the company offers investors an opportunity to gain a stake in an organization catering to this new breed of omni-users and their influencers.

The application’s potential is clearly illustrated by the interest it has generated in recent weeks. From September 4 to October 12, the Fan Pass platform added 246 new artists, accounting for a 410 percent increase in just six weeks.

“We are extremely encouraged by the ongoing swell of interest as the value of our Fan Pass platform continues to resonate in the artist community,” Friendable CEO Robert A. Rositano Jr. stated in a news release. “We believe the live streaming functionality, our full-circle offering and diverse revenue opportunities the platform offers will continue to drive exponential growth as management remains focused on building long-term shareholder value.”

Management Team

Robert A. Rositano Jr. is the co-founder and CEO of Friendable Inc. He oversees the daily management and operational duties of all areas of the business. He has over 20 years of experience as a serial entrepreneur, bringing in over $60 million in liquidity events for the companies he has created or managed. Before starting Friendable Inc. with his brother, Rositano was a founding member of the internet’s first IPO, Netcom Online Communications Inc. It was sold to ICG, then to EarthLink in 1995. He has been a co-founder of several successful ventures, including Simply Internet Inc., Nettaxi.com and America’s Biggest Inc., among others. He also authored one of the first web directories for MacMillan Publishers.

Dean Rositano is the co-founder and Chief Technology Officer of Friendable Inc. He handles the day-to-day operations and guides the technical direction of the company. He has over 15 years of executive management, financial management, high technology operations and internet architecture experience. Before co-founding Friendable Inc., Rositano co-founded several other companies, including Checkmate Mobile Inc. and Latitude Venture Partners LLC, among others.

Friendable Inc. (FDBL), closed Monday's trading session at $0.0066, off by 5.7143%, on 15,570,900 volume with 182 trades. The average volume for the last 3 months is 13.69M and the stock's 52-week low/high is $0.0061/$0.0979.

Recent News

Sugarmade, Inc. (OTC: SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (OTC: SGMD).

Sugarmade (OTC: SGMD), an innovator in the dynamic California cannabis sector, has closed on its most recent acquisition. The company intends to use the parcel located in Los Angeles as a new distribution/delivery hub for its Nug Avenue cannabis delivery segment. An article discussing the move quotes Sugarmade CEO Jimmy Chan, saying, “We are very excited to announce the upcoming location of our new Nug Avenue delivery hub, which is in a prime position to serve the downtown LA area. Our initial Nug Avenue location has been open for nearly six months and has established a strong brand with tremendous growth in membership — already exceeding 10,000 members and growing fast. Our remaining licenses can be applied to both expansion and verticalization of Nug Avenue operations as we continue to build a top-tier, farm-to-door leader in the California cannabis marketplace.” To view the full article, visit: https://cnw.fm/DGSGX

Sugarmade, Inc. (OTC: SGMD) is a product and brand marketing company investing in operations and technologies with disruptive potential. The company is focused on collaborating with real people in real-time to identify the emerging desires and behaviors poised to unlock new opportunities and pathways for growth. Sugarmade seeks to redefine the marketplace by nurturing an innovative and compelling relationship between brand, botany and business – resulting in both undeniable consumer value and an intriguing cross-pollination of revenue sources.

The company’s core strategic plan is centered on expanding its end-market access as a central player in the growing California cannabis delivery marketplace while developing its in-house cannabis production capacity to verticalize operations in the space. Through a combination of organic growth and strategic acquisitions, Sugarmade intends to develop a full farm-to-door vertically integrated cannabis business.

Brand Portfolio

Sugarmade has investments in a number of subsidiaries with active operations in the California cannabis sector. These include:

  • NUG Avenue – Sugarmade owns a 70% stake in NUG Avenue, a cannabis delivery service based in Southern California providing hand-selected top-shelf products from Stiiizy, Kanha, PlugPlay and more.
  • BudCars – Sugarmade is an investor in cannabis delivery service of BudCars’ first operating location in Sacramento, California. BudCars is an online-shopping experience designed to provide new customers with an easy way to discover and order cannabis products within minutes.

Acquisition of Lemon Glow Company

On May 17, 2021, Sugarmade took a major step toward closing the loop on what its management team believes to be one of the most promising vertically integrated cannabis models in the thriving California market when it announced the signing of a definitive agreement for its acquisition of Lemon Glow Company Inc.

The Lemon Glow acquisition includes 640 acres of property, 32 of which have already been designated for outdoor cannabis cultivation. Per the company’s news release, the annual potential cultivation yield at the property is estimated to be approximately 4,000 pounds of dry trimmed cannabis flower per acre per year, which represents approximately 128,000 pounds, or 64 tons, of dry trimmed cannabis flower per year in total.

Notably, Sugarmade also benefits from the acquisition in terms of team capital, as Lemon Glow executive team members will stay on and become the core management team at the cannabis cultivation site, granting the operation over 30 years of cannabis cultivation experience.

“The Lemon Glow team are tremendous additions to the Sugarmade team,” Jimmy Chan, CEO of Sugarmade, commented in announcing the definitive agreement. “They have vast experience and established skills, as well as intricate knowledge of the property and its local grow context. That’s an enormous added value proposition in this deal. We look forward to bringing them on board, ramping up operations at the property, and taking key steps toward delivering on the promise of Sugarmade’s farm-to-door vision.”

Market Opportunity

The California cannabis industry has continued to record tremendous growth since voters approved a measure to legalize recreational use of the plant in 2016. According to data from MJBizDaily, California’s legal market hit $4.4 billion in sales in 2020, up from $2.8 billion in 2019 and $1.4 billion in 2018.

Those figures highlight California’s status as the largest legal cannabis market in the world. With roughly 28 million residents over the age of 21, California is more than twice the combined size of the four states (Arizona, New Jersey, Montana and North Dakota) that legalized cannabis in 2020.

The COVID-19 pandemic was a key driver in the growth of cannabis delivery services throughout the state in 2020. One California cannabis delivery firm reported a 60% increase in new delivery customer sign-ups in the 30 days following the March 13, 2020, declaration of a national emergency. As a result of this boom, tech companies in cannabis ecommerce were able to dramatically increase their market share.
Sugarmade’s continued efforts to develop a farm-to-door vertically integrated cannabis business position it to capitalize on these trends as the California cannabis industry continues to expand moving forward.

Management

Jimmy Chan is the CEO of Sugarmade. He is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Sugarmade, Inc. (OTC: SGMD), closed Monday's trading session at $0.0017, off by 5.5556%, on 44,896,819 volume with 186 trades. The average volume for the last 3 months is 44.897M and the stock's 52-week low/high is $0.0007/$0.02.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

closed Wednesday's trading